These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 895269)

  • 1. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA; Jogestrand T; Kaijser L; Olsson AG
    Lakartidningen; 1977 Aug; 74(31):2629-33. PubMed ID: 895269
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD; Kawai S; Karadedos C; Bartels D
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1624-5. PubMed ID: 699778
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD)--a preliminary report on a placebo-controlled double-blind study.
    Diehm C; Stammler F; Hübsch-Müller C; Eckstein HH; Simini B
    Vasa Suppl; 1987; 17():52-6. PubMed ID: 3551154
    [No Abstract]   [Full Text] [Related]  

  • 4. Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans.
    Olsson AG; Thyresson N
    Acta Derm Venereol; 1978; 58(5):467-72. PubMed ID: 82360
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of peripheral arterial occlusive disease in stage IIb with intermittent short-term infusion of prostaglandin E1.
    Zanke BW; Hach W; Ozen Y; Sauerwein G
    Vasa Suppl; 1987; 17():36-8. PubMed ID: 3470964
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modification of collateral arteries by intra-arterial prostaglandin El infusion].
    Rudofsky G
    Vasa Suppl; 1987; 20():215-7. PubMed ID: 3480596
    [No Abstract]   [Full Text] [Related]  

  • 8. A multi-clinical double blind study with PGE, (alpha-cyclodextrin clathrate) in patients with ischemic ulcer of the extremities.
    Sakaguchi S; Kusaba A; Mishima Y; Kamiya K; Nishimura A; Furukawa K; Shionoya S; Kawashima M; Katsumura T; Sakuma A
    Vasa; 1978; 7(3):263-6. PubMed ID: 695874
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-arterial alprostadil for nonatherosclerotic vasculopathy.
    Wooster DL; Shamess CJ; Madras PN; Keystone EC
    JAMA; 1981 May; 245(18):1846-9. PubMed ID: 7230371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin E1 in chronic arterial disease--a multicenter study.
    Trübestein G; Diehm C; Gruss JD; Horsch S
    Vasa Suppl; 1987; 17():39-43. PubMed ID: 3470965
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H; Lammersen T
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1283-5. PubMed ID: 4040847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.
    Hirai M; Nakayama R
    Br J Surg; 1986 Jan; 73(1):20-3. PubMed ID: 3947867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery.
    Fietze-Fischer B; Gruss JD; Bartels D; Vargas-Montano H; Stritter W
    Vasa Suppl; 1987; 17():23-5. PubMed ID: 3470961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of arterial insufficiency in the lower extremities by intra-arterial injection].
    van der Molen HR
    Phlebologie; 1987; 40(1):157-69. PubMed ID: 3575431
    [No Abstract]   [Full Text] [Related]  

  • 16. Reaction of transcutaneous PO2 and laser Doppler flow signal on intraarterial infusion of PGE1 and nucleotide phosphates in patients with peripheral arterial occlusive disease.
    Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1987; 17():17-22. PubMed ID: 3470960
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous prostaglandin E1 in severe peripheral vascular disease.
    Carlson LA; Olsson AG
    Lancet; 1976 Oct; 2(7989):810. PubMed ID: 61488
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.
    Feldman SM; Alpert J; Dick LS; Brief DK; Goldenkranz R; Brener BJ; Parsonnet V
    J Med Soc N J; 1982 Dec; 79(13):985-7. PubMed ID: 6961223
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.
    Hirai M; Nanki M; Nakayama R
    Angiology; 1985 Jul; 36(7):407-13. PubMed ID: 4040721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial.
    Schuler JJ; Flanigan DP; Holcroft JW; Ursprung JJ; Mohrland JS; Pyke J
    J Vasc Surg; 1984 Jan; 1(1):160-70. PubMed ID: 6384558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.